This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

DATATRAK Participates In March Industry Events

CLEVELAND, March 4, 2013 /PRNewswire/ -- D ATATRAK International, Inc. (OTCQX: DATA), a leader in developing cloud-based, unified eClinical® technologies and delivering related services for the clinical trials industry, today announced its participation at industry events during the month of March.


25 th Annual EuroMeeting RAI, Amsterdam, The Netherlands March 4-6, 2013Booth #840

Dr. Bill Gluck, D ATATRAK's VP of Clinical and Consulting Services, is chairing the session Adoption Of Game Changing Technologies on Wednesday, March 6 from 11:00AM - 12:30PM.

D ATATRAK is exhibiting at the DIA's Annual EuroMeeting, which attracts well over 3,000 professionals from more than 50 countries from the biopharmaceutical industry, contract research and service organisations, academic research centres, regulatory agencies and health ministries as well as patient organisations. This convergence affords participants the opportunity to network with professional colleagues from around the world.  For more information, visit

HIMSS 13 Annual Conference and Exhibition New Orleans, LA March 3-7, 2013

D ATATRAK is attending the HIMSS 13 Annual Conference and Exhibition to ensure our teams have the opportunity to discuss the latest advances in leveraging technology, current regulatory mandates and quality policies.  The week-long conference includes more than 1100 world class exhibitors and covers topics such as Meaningful Use, ICD-10/HIPAA 5010 compliance, Affordable Care Act, EHR and Heath IT Issues. For more information on the conference, see

CBI ClinTech (CTMS, eTMF, Portal, EDC) Philadelphia, PA March 11-13, 2013

Chris Wilke, Chief Technology Officer of D ATATRAK, presents a case study during the Clinical System Integrations Operational Strategies and Technical Blueprints to Achieve Interoperability of CTMS, EDC, Quality Risk Management Systems and IVRS session on Monday, March 11, 2013 at 2:45PM.

DATATRAK is sponsoring, exhibiting and presenting at the ClinTech 2013 Conference – Implement, Manage and Integrate Systems to Advance Clinical Trials.  Learn more about the latest applications and strategies to meet today's clinical demands, including a Cloud Seminar to discuss the benefits of Cloud hosting.  To learn more about this CBI hosted event, see

ACDM Conference (Association for Clinical Data Management)Wokefield Park, Berkshire, UK March 17-19

William Gluck, PhD, will be presenting the session Using Technology to Integrate Clinical Data Management and Clinical Operations on Monday, March 18 th at 3:20PM.

D ATATRAK will be exhibiting and speaking at the ACDM Annual Conference 2013, which brings together all levels of staff from Data Management departments in the major biopharmaceutical companies and Clinical research organizations.  The ACDM Conference provides an environment to discuss standards as well as enhance individual skills, knowledge and professional development of its members. See for more information.


D ATATRAK is the leader of unified eClinical® technologies and related services for the clinical trials industry.  Using the D ATATRAK ONE™ multi-product, cloud-based clinical research platform, D ATATRAK 's Clinical and Consulting Services™ group assists clients in conducting Phase I-IV drug and device studies in multiple languages throughout the world. D ATATRAK has offices located in Cleveland, Ohio; Bryan, Texas; and Cary (RTP), North Carolina. For more information, visit

Except for the historical information contained in this press release, the statements made in this release are forward-looking statements. These forward-looking statements are made based on management's expectations, assumptions, estimates and current beliefs concerning the operations, future results and prospects of the Company and are subject to uncertainties and factors which are difficult to predict and, in many instances, are beyond the control of the Company, and which could cause actual results to differ materially from those contemplated in these forward-looking statements.  For a list of certain factors that may cause actual results to differ materially from those contemplated in these forward looking statements, please see the Company's report filed with the OTCQX Market on November 14, 2012 announcing its results for the three-month period ending September 30, 2012. The Company undertakes no obligation to update publicly or revise any forward-looking statement whether as a result of new information, future events or otherwise.

SOURCE DATATRAK International, Inc.

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,888.35 +168.43 0.95%
S&P 500 2,102.63 +22.22 1.07%
NASDAQ 5,156.3060 +47.64 0.93%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs